Design, synthesis, and structure-activity relationship of novel CCR2 antagonists

被引:19
|
作者
Kothandaraman, Shankaran [1 ]
Donnely, Karla L. [1 ]
Butora, Gabor [1 ]
Jiao, Richard [1 ]
Pasternak, Alexander [1 ]
Morriello, Gregori J. [1 ]
Goble, Stephen D. [1 ]
Zhou, Changyou [1 ]
Mills, Sander G. [1 ]
MacCoss, Malcolm [1 ]
Vicario, Pasquale P. [2 ]
Ayala, Julia M. [2 ]
DeMartino, Julie A. [2 ]
Struthers, Mary [2 ]
Cascieri, Margaret A. [2 ]
Yang, Lihu [1 ]
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Immunol, Rahway, NJ 07065 USA
关键词
CCR2; Antagonist; Chemotaxis; Aminocyclopentane carboxamide; Reductive aminations; CHEMOATTRACTANT PROTEIN-1 MCP-1; SMALL-MOLECULE; RECEPTOR ANTAGONISTS; CHEMOKINE RECEPTOR-2; HIGHLY POTENT; ATHEROSCLEROSIS; DERIVATIVES; ALCOHOLS; CHEMOTAXIS; DISCOVERY;
D O I
10.1016/j.bmcl.2008.12.050
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 1-aminocyclopentyl-3-carboxyamides incorporating substituted tetrahydropyran moieties have been synthesized and subsequently evaluated for their antagonistic activity against the human CCR2 receptor. Among them analog 59 was found to posses potent antagonistic activity. (C) 2009 Published by Elsevier Ltd.
引用
收藏
页码:1830 / 1834
页数:5
相关论文
共 50 条
  • [21] Structure-activity relationship studies:: M2 and CCR5 receptor antagonists
    Boyle, CD
    Palani, A
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (10) : 1155 - 1169
  • [22] Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines
    Yokoyama, Kazuhiro
    Ishikawa, Noriko
    Igarashi, Susumu
    Kawano, Noriyuki
    Masuda, Naoyuki
    Hamaguchi, Wataru
    Yamasaki, Shingo
    Koganemaru, Yohei
    Hattori, Kazuyuki
    Miyazaki, Takahiro
    Ogino, Shin-ichi
    Matsumoto, Yuzo
    Takeuchi, Makoto
    Ohta, Mitsuaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (01) : 64 - 73
  • [23] Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines
    Yokoyama, Kazuhiro
    Ishikawa, Noriko
    Igarashi, Susumu
    Kawano, Noriyuki
    Hattori, Kazuyuki
    Miyazaki, Takahiro
    Ogino, Shin-ichi
    Matsumoto, Yuzo
    Takeuchi, Makoto
    Ohta, Mitsuaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (14) : 7021 - 7032
  • [24] Design and synthesis of novel small molecule CCR2 antagonists: Evaluation of 4-aminopiperidine derivatives
    Vilums, M.
    Zweemer, A. J. M.
    Dekkers, S.
    Askar, Y.
    de Vries, H.
    Saunders, J.
    Stamos, D.
    Brussee, J.
    Heitman, L. H.
    IJzerman, A. P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (23) : 5377 - 5380
  • [25] Design and synthesis of novel CCR2 antagonists: Investigation of non-aryl/heteroaryl binding motifs
    Trujillo, John I.
    Huang, Wei
    Hughes, Robert O.
    Rogier, D. Joseph
    Turner, Steven R.
    Devraj, Rajesh
    Morton, Philip A.
    Xue, Chu-Biao
    Chao, Ganfeng
    Covington, Maryanne B.
    Newton, Robert C.
    Metcalf, Brian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1827 - 1831
  • [26] In vivo activity of an azole series of CCR2 antagonists
    Smethurst, Chris A.
    Bevan, Nicola
    Brooks, Carl
    Emmons, Amanda
    Gough, Peter J.
    Mookherjee, Claudette
    Moores, Kitty
    Peace, Simon
    Philp, Joanne
    Piercy, Val
    Watson, Steve P.
    Zippoli, Mara
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (23) : 7252 - 7255
  • [27] Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists
    Hossain, Nafizal
    Ivanova, Svetlana
    Timen, Asa Sjoholm
    Bergare, Jonas
    Mussie, Tesfaledet
    Bergstrom, Lena
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (14) : 4026 - 4030
  • [28] Design, synthesis, and structure-activity relationship of novel non-imidazole histamine H3 antagonists
    Liu, HQ
    Altenbach, RJ
    Miller, TR
    Esbenshade, TA
    Hancock, AA
    Cowart, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2567 - U2568
  • [29] CCR1 and CCR2 Antagonists
    Zimmermann, Henning W.
    Sterzer, Viktor
    Sahin, Hacer
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (13) : 1539 - 1552
  • [30] DESIGN, SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES FOR IMIDAZOLYL QUINOXALINES AS AMPA RECEPTOR ANTAGONISTS
    OHMORI, J
    SHIMIZUSASAMATA, S
    OKADA, M
    SAKAMOTO, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 178 - MEDI